ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1031

Induction of Pro-Apoptotic Noxa Expression By Ursolic Acid Sensitizes Rheumatoid Arthritis Synovial Fibroblasts to Apoptosis: A Role of Mir-181a

Salahuddin Ahmed1, Laura Walsh2, Anil Singh1, Maria Beamer3, Kuladeep Sudini4 and Douglas Leaman4, 1Department of Pharmaceutical Sciences, Washington State University, Spokane, WA, 2Department of Pharmacology, University of Toledo, Toledo, OH, 3Department of Pharmacology, Department of Pharmacology, University of Toledo, Toledo, OH, 4Department of Biological Sciences, University of Toledo, Toledo, OH

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Apoptosis, rheumatoid arthritis, synovial cells, synovial fluid, synovium, therapeutic targeting and tissue remodeling

  • Tweet
  • Email
  • Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:  In rheumatoid arthritis (RA), the paucity of pro-apoptotic protein expression may significantly contribute to the resistance of synovial fibroblasts (FLS) to apoptosis. In the present study, we evaluated if inducing the expression of pro-apoptotic protein Noxa in RA-FLS using a potent anti-inflammatory pentacyclic triterpenoid uroslic acid (UA) triggers apoptosis and studied the underlying mechanism.

Methods:  Effects of UA (2.5-10 μM) on human RA-FLS morphology and cell viability were determined by microscopy and a colorimetric MTT/SRB cell viability assays. Mechanism of UA’s activity was modulated experimentally by using the siRNA or plasmid overexpression approaches. Epigenetic regulation of Noxa by microRNA-181a (mir-181a) was studied using the microarray and qRT-PCR methods. Apoptosis was measured by the cleavage of caspase-3 and poly-ADP-ribose polymerase (PARP). Western blotting was used to evaluate the apoptosis signaling mediators, Noxa, and Mcl-1 expression. 

Results:  UA (2.5-20 μM) decreased the cell viability of RA-FLS in a dose-dependent manner. Importantly, UA (10 μM) selectively induced Noxa expression within 3 h to ~2-3 fold in RA-FLS (p<0.05; n=4). Induction of Noxa led to the consequent downregulation of Mcl-1 expression and apoptosis by 24 h of UA treatment (p<0.05; n=3). The inhibition of Mcl-1 expression by UA resulted in the sensitization of RA-FLS to TRAIL-induced PARP cleavage and apoptosis. Overexpression of Noxa using a plasmid vector targeting Noxa was effective in making RA-FLS susceptible to apoptosis. Using a siRNA method to block Noxa expression, we found that the RA-FLS apoptosis-inducing activity of UA was significantly blocked suggesting that UA induced apoptosis in RA-FLS primarily through Noxa upregulation. Confirmatory studies using WT and Noxa-/- BMK cells showed that UA efficiently induced apoptosis in WT cells but had no effect in Noxa-/- counterparts (p<0.01; two independent experiments). Interestingly, transfection of stably expressing Noxa in Noxa-/- BMK cells restored the apoptosis inducing capability of UA. MicroRNA array analysis showed a significant decrease in RA-FLS mir-181a expression, a miRNA known to facilitate apoptosis, by ~30% as compared to the normal FLS (p<0.05). We also found that UA (5-10 μM) was capable of inducing mir-181a expression in RA-FLS as compared to the non-stimulated samples suggesting that UA-induced Noxa expression and consequent apoptosis in RA-FLS may be mediated epigenetically via upregulation of mir-181a.

Conclusion:  Our novel findings indicate that inducing Noxa expression by UA in RA-FLS effectively induces apoptosis and this effect is partly mediated through mir-181a. Thus, developing therapeutic strategies that can selectively upregulate Noxa  and/or modulate mir-181a to induce apoptosis in RA-FLS may have potential therapeutic application for the treatment of RA.


Disclosure:

S. Ahmed,
None;

L. Walsh,
None;

A. Singh,
None;

M. Beamer,
None;

K. Sudini,
None;

D. Leaman,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/induction-of-pro-apoptotic-noxa-expression-by-ursolic-acid-sensitizes-rheumatoid-arthritis-synovial-fibroblasts-to-apoptosis-a-role-of-mir-181a/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology